Intravenous (IV) Ketamine is used by MASPP as a treatment forReflex Sympathetic Dystrophy (RSD), also known as Complex Regional Pain Syndrome (CRPS). RSD/CRPS is a severe chronic pain condition characterized by sensory, autonomic, motor and dystrophic signs and symptoms. The pain in this condition is continuous and it worsens over time.

MASPP provides the Awake Technique, a low dose ketamine infusion over of a period of tens days in our outpatient surgical center. The drug ketamine manipulates NMDA receptors by rebooting aberrant brain activity. While low-dose ketamine therapy is established as a generally safe procedure, reported side effects in some patients have included hallucinations, dizziness, lightheadedness and nausea.

Medical studies show approximately 60-85% of patients who undergo IV Ketamine treatment have shown improvement measured by increased activity, reduction of medication, and improved lifestyles. Some have discarded wheelchairs, walkers, and canes, and others have increased activities or have returned to work.

Click here to view our IV Ketamine brochure.